Encorafenib(LGX-818) Catalog No : 179308

Product Name	Encorafenib(LGX-818)
Iupac Chemical Name	(S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Synonyms	Encorafenib;LGX818; LGX-818; LGX 818;
Molecular Formula	C22H27ClFN7O4S
Molecular Weight	540.01
Smile	O=C(OC)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C3=CC(Cl)=CC(NS(=O)(C)=O)=C3F)=N1
InChiKey	CMJCXYNUCSMDBY-ZDUSSCGKSA-N
InChi	InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1
Cas	1269440-17-6

Appearance	off-white solid
Purity	>98%
Solubility	Soluble in DMSO, not in water
Storage	Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs
Quality control

Encorafenib, also known as LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis and was disclosed at the spring 2013 American Chemical Society meeting in New Orleans.

Encorafenib(LGX-818) Catalog No : 179308

Chemical Information

Technical Data

Description

Chemical Structure

Package

Quick Order

Contact Us